Special precautions for disposal and other handling: Needles and NovoRapid FlexPen or Penfill must not be shared. The cartridge must not be refilled.
NovoRapid must not be used if it does not appear clear and colourless or if it has been frozen.
The patient should be advised to discard the needle after each injection.
In case of emergency in current NovoRapid users (hospitalisation or insulin pen malfunction), NovoRapid can be withdrawn with an U100 insulin syringe from the FlexPen or cartridge.
Incompatibilities: Substances added to NovoRapid may cause degradation of insulin aspart.
This product must not be diluted or mixed with other products, except infusion fluids as described in Posology under Dosage & Administration.